
Fresh Covid-19 vaccine reports are on the horizon, with drugmakers including Pfizer Inc. expecting to obtain more trial data as early as this week. The updates are eagerly awaited as the pandemic accelerates, with the U.S. surpassing 11 million cases.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push